Vadadustat for treating symptomatic anaemia in adults having dialysis for chronic kidney disease [ID3821]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 20 November 2024
Dapagliflozin for treating chronic kidney disease [ID6411]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 12 February 2025
Sparsentan for treating primary IgA nephropathy [ID6308]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 30 April 2025
Canagliflozin for treating chronic kidney disease in people with type 2 diabetes [ID1653]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Daprodustat for treating anaemia in people with chronic kidney disease [ID3987]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC